This funding opportunity is eligible for a pilot, allowing researchers to embed a study within a trial. These studies should evaluate alternative ways of undertaking a trial process.
Application dates: 05 April 2018 to 01 August 2018
The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic:
18/31 Discontinuation of growth hormone treatment in pubertal children
In order to apply you will need to carefully review the:
The deadline for applications is 1pm, 1 August 2018.
*Please note: This document is to be used as a guide and to assist with completion of the on-line application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.
All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the TSC/SSC Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.
Applications received by the advertised closing date will be considered at a first-stage board, and successful applicants will then be invited to submit a full proposal. Applicants will have eight weeks to complete and submit a full application form, which will then be considered at the following HTA funding decision board. For more information, please read the commissioning brief.